Planc Bio Pharm

Planc Bio PharmPlanc Bio Pharm

Planc Bio Pharm

Stealth modeStealth Mode

Developing novel therapeutic agents for oncology and other diseases.

Inactive

About

Planc Bio Pharm is a biotechnology company focused on the discovery and development of innovative therapeutic agents. Their primary focus is on oncology, aiming to create new treatments for cancer patients. The company leverages its scientific expertise to advance novel drug candidates through the development pipeline.
Frequently asked

What does Planc Bio Pharm do?

Planc Bio Pharm is a biotechnology company focused on the discovery and development of innovative therapeutic agents. Their primary focus is on oncology, aiming to create new treatments for cancer patients. The company leverages its scientific expertise to advance novel drug candidates through the development pipeline.

What industry does Planc Bio Pharm operate in?

Planc Bio Pharm operates in Biotech, MedTech, HealthTech, Drug Discovery, Oncology, Therapeutics.

What is Planc Bio Pharm's current status?

Planc Bio Pharm's current operating status is: Inactive.

New entrants in Biotech
Last 90 days
37
New entrants
12.3
Per month
2.9
Per week

An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 8 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.

Scores
Measured, not editorial
Agent Readiness
35/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Site Speed
74/100

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.